Clinical prognostic factors affecting survival in patients with newly diagnosed Glioblastoma Multiforme (GBM).

被引：0
|
作者：
Gorlia, T
Stupp, R
Eisenhauer, EA
Mirimanoff, RO
Van Den Bent, MJ
Belanger, K
Lacombe, D
Allgeier, A
机构：
[1] NCIC, Brain Grp, EORTC, Kingston, ON, Canada
[2] NCIC, Radiotherapy Grp, EORTC, Kingston, ON, Canada
[3] NCIC, Clin Trials Grp, Kingston, ON, Canada
[4] Eortc Data Ctr, Brussels, Belgium
[5] CHU Vaudois, CH-1011 Lausanne, Switzerland
[6] Erasmus Univ, Med Ctr, Rotterdam, Netherlands
[7] CHUM, Hop Notre Dame, Montreal, PQ, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9599
引用
收藏
页码：859S / 859S
页数：1
相关论文
共 50 条
  • [21] MR PARAMETERS AS NONINVASIVE BIOMARKERS FOR PREDICTING SURVIVAL IN NEWLY DIAGNOSED PATIENTS WITH GLIOBLASTOMA MULTIFORME
    Chang, Susan M.
    Nelson, Sarah J.
    Saraswathy, Suja
    Crawford, Forrest
    Khayal, Inas
    [J]. NEURO-ONCOLOGY, 2009, 11 (02) : 223 - 223
  • [22] Long-term survival of patients with glioblastoma multiforme (GBM)
    Smoll, Nicolas R.
    Schaller, Karl
    Gautschi, Oliver P.
    [J]. JOURNAL OF CLINICAL NEUROSCIENCE, 2013, 20 (05) : 670 - 675
  • [23] Prognostic Factors of Survival in Glioblastoma Multiforme Patients-A Retrospective Study
    Serban, Georgiana
    Tamas, Flaviu
    Balasa, Rodica
    Manu, Doina
    Tamas, Corina
    Balasa, Adrian
    [J]. DIAGNOSTICS, 2022, 12 (11)
  • [24] Evaluation of Survival and Prognostic Factors for Elderly Patients of 65 With Glioblastoma Multiforme
    Zerounian, S.
    Simonyan, D.
    Michaud, K.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S255 - S255
  • [25] Relapse therapy in patients with glioblastoma multiforme Clinical factors and survival
    Steffens, R.
    Lahmer, G.
    Putz, F.
    Eyuepoglu, I
    Buchfelder, M.
    Fietkau, R.
    Semrau, S.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2014, 190 : 23 - 23
  • [26] Treatment of newly diagnosed glioblastoma multiforme
    Nieder, C
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (14) : 3179 - 3180
  • [27] Outcome of grade 3 and 4 cytopenia in newly diagnosed glioblastoma multiforme (GBM) patients treated with temozolomide (TMZ).
    Sanchez, B. E.
    Munoz, J.
    Ali, H. Y.
    Anderson, J. M.
    Kuriakose, P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [28] MGMT methylation status may predict survival in elderly patients with newly diagnosed glioblastoma (GBM)
    Gerstner, E. R.
    Yip, S.
    Wang, D. L.
    Louis, D. N.
    Iafrate, A. J.
    Batchelor, T. T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [29] Use of tissue microarrays (TMA) in evaluating prognostic factors in 100 glioblastoma multiforme (GBM) patients
    Chiesa-Vottero, AG
    Prayson, RA
    Castilla, EA
    Hartke, M
    Rybicki, LA
    Tubbs, RR
    Vogelbaum, M
    Barnett, G
    [J]. MODERN PATHOLOGY, 2003, 16 (01) : 289A - 289A
  • [30] Use of tissue microarrays (TMA) in evaluating prognostic factors in 100 glioblastoma multiforme (GBM) patients
    Chiesa-Vottero, AG
    Prayson, RA
    Castilla, EA
    Hartke, M
    Rybicki, LA
    Tubbs, RR
    Vogelbaum, M
    Barnett, G
    [J]. LABORATORY INVESTIGATION, 2003, 83 (01) : 289A - 289A
12345